Evidence map›Paper›PMID 34992224›Full record

ArticleJournal of exposure science & environmental epidemiology2023

Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana.

Ashley M Geczik, Roni T Falk, Xia Xu, Beatrice Wiafe-Addai, Joel Yarney, Baffour Awuah, Richard Biritwum, Verna Vanderpuye, Florence Dedey, Ernest Adjei and 14 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of exposure science & environmental epidemiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 9 institutions in 3 countries.

Ashley M GeczikDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Roni T FalkDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Xia XuProtein Characterization Laboratory, Leidos-Frederick, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Beatrice Wiafe-AddaiPeace and Love Hospital, Kumasi, Ghana.
Joel YarneyKorle Bu Teaching Hospital, Accra, Ghana.
Baffour AwuahKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Richard BiritwumUniversity of Ghana, Accra, Ghana.
Verna VanderpuyeKorle Bu Teaching Hospital, Accra, Ghana.
Florence DedeyKorle Bu Teaching Hospital, Accra, Ghana.
Ernest AdjeiKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Francis AitpillahKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Ernest Osei-BonsuKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Joseph OppongKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Nicholas TitiloyeKomfo Anokye Teaching Hospital, Kumasi, Ghana.
Lawrence EduseiKorle Bu Teaching Hospital, Accra, Ghana.
Kofi NyarkoUniversity of Ghana, Accra, Ghana.
Joe-Nat Clegg-LampteyKorle Bu Teaching Hospital, Accra, Ghana.
Seth WiafeLoma Linda University, School of Public Health, Loma Linda, CA, USA.
Daniel AnsongKwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Thomas U AhearnDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Jonine FigueroaThe University of Edinburgh, Cancer Research UK Edinburgh Center, Edinburgh, UK.
Montserrat Garcia-ClosasDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Louise A Brinton *Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Britton Trabert *Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. britton.trabert@nih.gov.
Komfo Anokye Teaching Hospital · GHKorle Bu Teaching Hospital · GHNational Institutes of Health · USNational Cancer Institute · USUniversity of Ghana · GHEdinburgh Cancer Research · GBFrederick National Laboratory for Cancer Research · USKwame Nkrumah University of Science and Technology · GHLoma Linda University · US

Funding

Hormone-Related CancersZIACP010126 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GIERACH, GRETCHEN · 2009 to 2025
$103.5M
General Studies of EpidemiologyZIACP010167 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI KRAFT, PETER · 2009 to 2025
$9.2M
Intramural NIH HHS ZIA CP010167
6 · The paper itself

Abstract

backgroundHair relaxers and skin lighteners have been commonly used by African women, with suggestions that they may have hormonal activity.

objectivesTo investigate the relationship of hair relaxer and skin lightener use to serum estrogen/estrogen metabolite levels.

methodsWe utilized the postmenopausal population-based controls of the Ghana Breast Health Study to estimate adjusted geometric means (GM) and 95% confidence intervals of individual circulating estrogen levels by hair relaxer/skin lightener exposure categories.

resultsOf the 585 postmenopausal women included in our analysis, 80.2% reported hair relaxer use and 29.4% skin lightener use. Ever hair relaxer use was positively associated with estriol (adjusted GM 95.4 pmol/L vs. never 74.5, p value = 0.02) and 16-epiestriol (20.4 vs. 16.8, p value = 0.05) particularly among users of lye-based hair relaxers. Positive associations between scalp burns and unconjugated estrogens were observed (e.g., unconjugated estrone: 5+ scalp burns 76.9 [59.6-99.2] vs. no burns 64.0 [53.7-76.3], p-trend = 0.03). No association was observed between use of skin lighteners and circulating estrogens. SIGNIFICANCE: This study presents evidence that circulating 16-pathway estrogens (i.e., estriol and 16-epiestriol) may be increased in users of lye-based hair relaxer products. Among hair relaxer users, unconjugated estrogen levels were elevated in women with a greater number of scalp burns. IMPACT STATEMENT: In this population-based study of hair relaxer and skin lightener use among postmenopausal women in Ghana, altered estrogen metabolism was observed with hair relaxer use, particularly among women using lye-based products or with a greater number of scalp burns. In contrast, skin lightener use was not associated with differences in estrogen metabolism in this population. Continued investigation of the potential biological impact on breast cancer risk of hair relaxer use is warranted.

Indexed as

EstrogensLyeEstriolFemaleGhanaHairHumansPostmenopauseEstriolEstrogensLyeEndogenous estrogensGhanaHair relaxer usePostmenopausal womenSkin lightener use

Identifiers

PMID34992224
PMCPMC9256865
OpenAlexW4206458998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.